scholarly article | Q13442814 |
P50 | author | Carl L. Keen | Q117314033 |
Andrea T. Borchers | Q131708971 | ||
Carlo Selmi | Q42356913 | ||
M. Eric Gershwin | Q73297886 | ||
P2093 | author name string | Frederick J Meyers | |
P2860 | cites work | The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance | Q80826759 |
Oral administration of Bifidobacterium bifidum G9-1 suppresses total and antigen specific immunoglobulin E production in mice | Q81003113 | ||
Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion | Q81096856 | ||
Decreased numbers of FoxP3-positive and TLR-2-positive cells in intestinal mucosa are associated with improvement in patients with active inflammatory bowel disease following selective leukocyte apheresis | Q81221449 | ||
In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria | Q81226620 | ||
IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model | Q81235051 | ||
Timing of bifidobacterium administration influences the development of allergy to ovalbumin in mice | Q81332927 | ||
Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern | Q81338163 | ||
Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease | Q81357285 | ||
Antiallergic effects of Lactobacillus pentosus strain S-PT84 mediated by modulation of Th1/Th2 immunobalance and induction of IL-10 production | Q81392671 | ||
Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial | Q81432992 | ||
The genetics of immunoregulatory T cells | Q81447097 | ||
Effects of Lactobacillus acidophilus strain L-55 on experimental allergic rhinitis in BALB/c mice | Q81543166 | ||
Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology | Q81778140 | ||
Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis | Q82173581 | ||
Probiotics modulate inflammatory cytokine secretion from inflamed mucosa in active ulcerative colitis | Q82632663 | ||
Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88 | Q83974804 | ||
Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines | Q80215416 | ||
Lactobacillus GG bacteria ameliorate arthritis in Lewis rats | Q80397086 | ||
The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients | Q80405421 | ||
Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis | Q80420270 | ||
Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-gamma release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates | Q80426976 | ||
Low breast milk TGF-beta2 is induced by Lactobacillus reuteri supplementation and associates with reduced risk of sensitization during infancy | Q80551997 | ||
Lactobacillus Acidophilus strain L-92 regulates the production of Th1 cytokine as well as Th2 cytokines | Q80657027 | ||
Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis | Q80691519 | ||
Basal lymphoid aggregates in ulcerative colitis colon: a site for regulatory T cell action | Q42523517 | ||
Modulation of human dendritic cell phenotype and function by probiotic bacteria | Q43004747 | ||
Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment | Q43005855 | ||
Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis | Q43628018 | ||
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. | Q43746137 | ||
Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells | Q45304815 | ||
Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination | Q45540910 | ||
Strain-dependent effects of probiotic lactobacilli on EAE autoimmunity | Q45795182 | ||
Direct regulatory immune activity of lactic acid bacteria on Der p 1-pulsed dendritic cells from allergic patients | Q46577653 | ||
Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study | Q46612029 | ||
Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells | Q46664235 | ||
Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models | Q46852650 | ||
Effect of oral administration of heat-killed Lactobacillus brevis SBC8803 on total and ovalbumin-specific immunoglobulin E production through the improvement of Th1/Th2 balance | Q46869549 | ||
Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. | Q46935325 | ||
A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis | Q46980839 | ||
Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy | Q47229738 | ||
DNA from probiotic bacteria modulates murine and human epithelial and immune function | Q47635337 | ||
Orally administered Lactobacillus strains differentially affect the direction and efficacy of the immune response | Q47743334 | ||
Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells | Q47945739 | ||
Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells | Q47961731 | ||
Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria | Q47962035 | ||
Role of the GALT in scrapie agent neuroinvasion from the intestine | Q48252446 | ||
Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice | Q48318531 | ||
Autoimmunity: from the mosaic to the kaleidoscope | Q48534857 | ||
Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans | Q50085670 | ||
Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells | Q51035102 | ||
Lactobacillus casei Shirota administered during lactation increases the duration of autoimmunity in rats and enhances lung inflammation in mice | Q51743349 | ||
Antiallergic effect of milk fermented with lactic acid bacteria in a murine animal model | Q51752045 | ||
Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. | Q51762291 | ||
Immunostimulatory oligodeoxynucleotide containing TTTCGTTT motif from Lactobacillus rhamnosus GG DNA potentially suppresses OVA-specific IgE production in mice | Q51791575 | ||
Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. | Q51797248 | ||
Autoantibodies to calcium channels in type 1 diabetes mediate autonomic dysfunction by different mechanisms in colon and bladder and are neutralized by antiidiotypic antibodies | Q52586859 | ||
Autoimmune cholangitis in NOD.c3c4 mice is associated with cholangiocyte-specific Fas antigen deficiency | Q53555327 | ||
Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta | Q53576197 | ||
No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial | Q53611721 | ||
Human antigen-presenting cells respond differently to gut-derived probiotic bacteria but mediate similar strain-dependent NK and T cell activation | Q54433671 | ||
Gut microbiota and development of atopic eczema in 3 European birth cohorts | Q54438776 | ||
Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease | Q54466275 | ||
Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model | Q54484151 | ||
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis | Q54511436 | ||
Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers | Q54523608 | ||
Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients | Q54536971 | ||
Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. | Q54746716 | ||
Immunostimulatory oligonucleotide, CpG-like motif exists in Lactobacillus delbrueckii ssp. bulgaricus NIAI B6. | Q54767823 | ||
Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. | Q55036595 | ||
Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. | Q55043289 | ||
Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. | Q55049062 | ||
Autoimmunity and persistent viral infection: Two sides of the same coin? | Q56959363 | ||
Probiotics for induction of remission in ulcerative colitis | Q24242963 | ||
Probiotics for maintenance of remission in Crohn's disease | Q24244110 | ||
Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius | Q24682955 | ||
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial | Q24685494 | ||
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial | Q28211907 | ||
Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people | Q28285488 | ||
Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial | Q28287413 | ||
Immunobiology of dendritic cells | Q29547465 | ||
Tolerogenic dendritic cells | Q29618755 | ||
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria | Q29619620 | ||
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance | Q29620412 | ||
Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells. | Q30442645 | ||
Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis | Q30442649 | ||
A key role of dendritic cells in probiotic functionality | Q30830505 | ||
Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement | Q33265418 | ||
Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases | Q33317883 | ||
Toll-like receptor 9-induced type I IFN protects mice from experimental colitis | Q33683729 | ||
Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells | Q33770489 | ||
Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria | Q33787825 | ||
Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization | Q33864114 | ||
Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids | Q33900587 | ||
Anatomical basis of tolerance and immunity to intestinal antigens | Q33965210 | ||
Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10. | Q33999211 | ||
Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells | Q34013041 | ||
Bacterial probiotic modulation of dendritic cells | Q34144168 | ||
Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function | Q34374501 | ||
Modulation of natural killer cell activity by supplementation of fermented milk containing Lactobacillus casei in habitual smokers. | Q34400266 | ||
Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin | Q34424372 | ||
The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans | Q34486626 | ||
Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant | Q34520453 | ||
Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro | Q34522706 | ||
Non-alcoholic fatty liver disease: the new epidemic and the need for novel nutritional approaches | Q37045018 | ||
Stress as a trigger of autoimmune disease | Q37055429 | ||
Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials | Q37088384 | ||
Set a thief to catch a thief: self-reactive innate lymphocytes and self tolerance. | Q37093001 | ||
Mechanisms of T regulatory cell function | Q37166838 | ||
Probiotics and liver disease | Q37187334 | ||
Celiac disease: from gluten to autoimmunity | Q37203009 | ||
Redox state, cell death and autoimmune diseases: a gender perspective. | Q37206804 | ||
Probiotic Leuconostoc mesenteroides ssp. cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production. | Q37212931 | ||
Reactive oxygen species generation at the plasma membrane for antibody control | Q37215803 | ||
Autoimmune thyroiditis and ROS. | Q37215808 | ||
Immunological tolerance and the autoimmune response | Q37215811 | ||
Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? | Q37215816 | ||
Autoimmunity and oxidatively modified autoantigens | Q37215828 | ||
Functional variability of antibodies upon oxidative processes | Q37215832 | ||
Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults | Q37240389 | ||
Live Lactobacillus rhamnosus [corrected] is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression | Q37521881 | ||
Innate immune responses of human neonatal cells to bacteria from the normal gastrointestinal flora | Q39672297 | ||
Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta | Q40102142 | ||
Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. | Q40373272 | ||
Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. | Q40398677 | ||
Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells | Q40403481 | ||
Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse | Q40409987 | ||
Functional modulation of enterocytes by gram-positive and gram-negative microorganisms | Q40580514 | ||
A new model of chronic colitis in SCID mice induced by adoptive transfer of CD62L+ CD4+ T cells: insights into the regulatory role of interleukin-6 on apoptosis | Q40606609 | ||
Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis | Q40685749 | ||
Adhesion of lactic acid bacteria to caco-2 cells and their effect on cytokine secretion. | Q40725779 | ||
Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood | Q41005375 | ||
Immunostimulatory oligonucleotides inhibit colonic proinflammatory cytokine production in ulcerative colitis | Q41945434 | ||
Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures | Q42018332 | ||
Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria | Q42134896 | ||
Induction of inflammation as a possible mechanism of probiotic effect in atopic eczema-dermatitis syndrome | Q34558301 | ||
Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients | Q34580564 | ||
The application of probiotics in cancer | Q34583587 | ||
The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2). | Q34591170 | ||
The role of the intestinal microbiota in the development of atopic disorders. | Q34665715 | ||
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial | Q34750864 | ||
Role of yoghurt in the prevention of colon cancer. | Q34763476 | ||
Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2 | Q34778968 | ||
Effects of probiotics on atopic dermatitis: a randomised controlled trial | Q35284723 | ||
Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria | Q35595154 | ||
Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. | Q35595783 | ||
Impact of lactic Acid bacteria on dendritic cells from allergic patients in an experimental model of intestinal epithelium | Q35741195 | ||
Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease | Q35827406 | ||
The X and why of xenobiotics in primary biliary cirrhosis | Q35916081 | ||
Bacterial translocation (BT) in cirrhosis | Q36050434 | ||
Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes. | Q36346442 | ||
Genetic complexity of autoimmune myocarditis | Q36445064 | ||
Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease | Q36655696 | ||
Gender as risk factor for autoimmune diseases | Q36721434 | ||
Balancing autoaggressive and protective T cell responses | Q36760821 | ||
Extreme genetic risk for type 1A diabetes in the post-genome era | Q36768347 | ||
The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia | Q36791429 | ||
Probiotics for the prevention or treatment of allergic diseases | Q36837941 | ||
Autophagy: highlighting a novel player in the autoimmunity scenario | Q36907987 | ||
Natural antibodies and cancer | Q36934928 | ||
The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE) | Q36938320 | ||
Potential target of infliximab in autoimmune and inflammatory diseases | Q36940168 | ||
Associated autoantibodies in celiac disease. | Q36940181 | ||
Innate and adaptive immune response to apoptotic cells | Q36948827 | ||
Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border | Q36949181 | ||
Regulatory pathways in inflammation | Q36984635 | ||
Insights into atherosclerosis therapy in antiphospholipid syndrome | Q36984674 | ||
Probiotics and remission of ulcerative colitis: a systematic review | Q37031840 | ||
Review article: Probiotics in gastrointestinal and liver diseases | Q37032747 | ||
Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo | Q57079498 | ||
Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa | Q57241187 | ||
An immunostimulatory DNA sequence from a probiotic strain ofBifidobacterium longuminhibits IgE productionin vitro | Q58797599 | ||
Immunomodulating potential of supplementation with probiotics: a doseâ response study in healthy young adults | Q58816514 | ||
Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma | Q59054619 | ||
Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions | Q59302401 | ||
Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles | Q59880418 | ||
Effect of probiotic Lactobacillus strains in children with atopic dermatitis | Q60291329 | ||
Monocyte-derived dendritic cells activated by bacteria or by bacteria-stimulated epithelial cells are functionally different | Q60648676 | ||
Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells | Q61276176 | ||
Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses | Q61569430 | ||
Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity | Q62638856 | ||
Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria | Q63727331 | ||
Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function | Q63916213 | ||
Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease | Q70489716 | ||
Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses | Q73292392 | ||
Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects | Q73516607 | ||
Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria | Q73592034 | ||
Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001 | Q73875693 | ||
AT oligonucleotides inducing B lymphocyte activation exist in probiotic Lactobacillus gasseri | Q73977101 | ||
The Effect of Oral Feeding of Lactobacillus casei Strain Shirota on Immunoglobulin E Production in Mice | Q74284091 | ||
Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes | Q74376675 | ||
Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects | Q74452704 | ||
Dietary intake of Lactobacillus rhamnosus HNOO1 enhances production of both Th1 and Th2 cytokines in antigen-primed mice | Q74509572 | ||
Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice | Q77152271 | ||
Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019 | Q77291999 | ||
Lactobacilli Differentially Modulate Expression of Cytokines and Maturation Surface Markers in Murine Dendritic Cells | Q77373909 | ||
Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice | Q77659986 | ||
Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial | Q79510179 | ||
Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial | Q79510185 | ||
A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis | Q79542237 | ||
Combined effect of different lactic acid bacteria strains on the mode of cytokines pattern expression in human peripheral blood mononuclear cells | Q79623077 | ||
An analysis of the effectiveness of heat-killed lactic acid bacteria in alleviating allergic diseases | Q79903350 | ||
Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial | Q79914666 | ||
The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention | Q79920849 | ||
Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism | Q79984979 | ||
Evaluation of immunomodulation by Lactobacillus casei Shirota: immune function, autoimmunity and gene expression | Q80019888 | ||
Induction of interleukin-12 by Lactobacillus strains having a rigid cell wall resistant to intracellular digestion | Q80087986 | ||
Effect of probiotics on vaccine antibody responses in infancy--a randomized placebo-controlled double-blind trial | Q80152195 | ||
Oral administration of an immunostimulatory DNA sequence from Bifidobacterium longum improves Th1/Th2 balance in a murine model | Q80154121 | ||
Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults | Q80172504 | ||
MyD88 but not TLR2, 4 or 9 is essential for IL-12 induction by lactic acid bacteria | Q80175927 | ||
P433 | issue | 1 | |
P921 | main subject | probiotics | Q1816730 |
P304 | page(s) | 26-46 | |
P577 | publication date | 2009-01-22 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Journal of Gastroenterology | Q15764399 |
P1476 | title | Probiotics and immunity | |
P478 | volume | 44 |